BCG Vaccine

"BCG Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.

Descriptor ID	D001500
MeSH Number(s)	D20.215.894.135.825.100
Concept/Terms	BCG Vaccine BCG Vaccine Vaccine, BCG Bacillus Calmette Guerin Vaccine Calmette Guerin Bacillus Vaccine Calmette's Vaccine Calmette Vaccine Calmettes Vaccine Vaccine, Calmette's

Below are MeSH descriptors whose meaning is more general than "BCG Vaccine".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Bacterial Vaccines [D20.215.894.135]
Tuberculosis Vaccines [D20.215.894.135.825]
BCG Vaccine [D20.215.894.135.825.100]

Below are MeSH descriptors whose meaning is related to "BCG Vaccine".

Below are MeSH descriptors whose meaning is more specific than "BCG Vaccine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "BCG Vaccine" by people in this website by year, and whether "BCG Vaccine" was a major or minor topic of these publications.

Bar chart showing 36 publications over 20 distinct years, with a maximum of 4 publications in 2020 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2004	1	0	1
2005	0	1	1
2007	1	1	2
2009	0	1	1
2010	0	1	1
2011	1	0	1
2012	1	0	1
2014	0	1	1
2015	1	0	1
2016	1	0	1
2017	1	0	1
2018	1	1	2
2020	1	3	4
2021	2	1	3
2022	1	3	4
2023	0	2	2
2024	1	2	3
2025	2	1	3
2026	2	0	2

Below are the most recent publications written about "BCG Vaccine" by people in Profiles.

Ogunsola AF, Lai R, Cavallo K, Tran AV, Beamer GL, Behar SM. BCG vaccination elicits protection against M. tuberculosis infection mediated by two phases of T cell immunity. JCI Insight. 2026 08 24; 11(16).

View in: PubMed
Korn P, Pallauf M, Herrera-Caceres JO, Lokeshwar S, Essien M, Small A, Raskolnikov D, Kleinmann N, Shvero A, Matin SF, Labbate C, Kaimakliotis H, Tachibana I, Linehan J, Choe J, Shah O, Movassaghi M, Huang W, Persily J, Perecman A, Canes D, Pessoa RR, Potretzke A, Raman JD, Singla N. Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma. World J Urol. 2026 May 19; 44(1).

View in: PubMed
Bridges K, Awany D, Gela A, Mwambene TD, Kurtz SL, Baker RE, Elkins KL, Sassetti CM, Scriba TJ, Lauffenburger DA. Cross-species blood transcriptional correlates of BCG-mediated protection against tuberculosis include innate and adaptive immune processes. JCI Insight. 2025 12 22; 10(24).

View in: PubMed
Anterasian C, Gela A, Mwambene TD, Shah JA, Ivie J, Dill-McFarland KA, Hanekom WA, Kiritsy MC, Sassetti CM, Musvosvi M, Hatherill M, Scriba TJ, Hawn TR. BCG induced innate immune response heterogeneity and susceptibility to pediatric tuberculosis. J Immunol. 2025 May 01; 214(5):936-946.

View in: PubMed
Seiden B, Ajay D, Cheung F, Clements M, Pietzak E. Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer. Curr Urol Rep. 2025 Jan 06; 26(1):24.

View in: PubMed
Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 12; 42(34):4095-4102.

View in: PubMed
Flores-Valdez MA, Peterson EJR, Aceves-Sánchez MJ, Baliga NS, Morita YS, Sparks IL, Saini DK, Yadav R, Lang R, Mata-Espinosa D, León-Contreras JC, Hernández-Pando R. Comparison of the transcriptome, lipidome, and c-di-GMP production between BCG?BCG1419c and BCG, with Mincle- and Myd88-dependent induction of proinflammatory cytokines in murine macrophages. Sci Rep. 2024 05 24; 14(1):11898.

View in: PubMed
Kurtz SL, Baker RE, Boehm FJ, Lehman CC, Mittereder LR, Khan H, Rossi AP, Gatti DM, Beamer G, Sassetti CM, Elkins KL. Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice. PLoS Pathog. 2024 03; 20(3):e1012069.

View in: PubMed
Lai R, Gong DN, Williams T, Ogunsola AF, Cavallo K, Lindestam Arlehamn CS, Acolatse S, Beamer GL, Ferris MT, Sassetti CM, Lauffenburger DA, Behar SM. Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis. J Clin Invest. 2023 07 03; 133(13).

View in: PubMed
Olive AJ, Smith CM, Baer CE, Coers J, Sassetti CM. Mycobacterium tuberculosis Evasion of Guanylate Binding Protein-Mediated Host Defense in Mice Requires the ESX1 Secretion System. Int J Mol Sci. 2023 Feb 02; 24(3).

View in: PubMed

People

Explore

Similar Concepts

Top Journals